Skip to content

A randomized controlled clinical trial for electroacupuncture in the treatment of different nerve branches of acute head and face herpes zoster

A randomized controlled clinical trial for electroacupuncture in the treatment of different nerve branches of acute head and face herpes zoster

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018541
Enrollment
Unknown
Registered
2018-09-23
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

therapy group:Electroacupuncture and moxibustion

Sponsors

Chengdu First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) meet the above diagnostic criteria; (2) Those who belong to the head and face herpes zoster; (3) between the ages of 18 and 80 years; (4) Those who did not take drugs such as oral or topical analgesics or received relevant treatment within one week prior to the election; (5) Consciousness of consciousness, complete cognitive function, no communication barriers; (6) There are no serious organ diseases such as severe heart, liver, kidney and blood system; (7) Patients with informed consent, willing to receive treatment, and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who do not have autonomy; 2. pregnant or lactating women; 3. Those who are intolerant of the operation of this test; 4. participated in other clinical trials in the past 3 months; 5. The patient or family member does not cooperate with the treatment.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale/Score;Self-made herpes zoster residual symptoms and signs;Hamilton Anxiety Scale;

Secondary

MeasureTime frame
Quality of life assessment scale;

Countries

China

Contacts

Public ContactQiu Ling

Chengdu University of Traditional Chinese Medicine

qoiling1@163.com+86 13550366617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026